News Center
Home>News Center>Foreign investment in China, medical equipment sonorous walking into new markets through mergers and
Foreign investment in China, medical equipment sonorous walking into new markets through mergers and

Social business June 14 news, "the company has an innovative internal evaluation - new product vitality index, medical products division goal is to strive to reach 40%." Recently, in the 7th Shanghai International Forum on Infection Control clearance, 3M China Limited Medical Products Division general manager of Wu Liang told "Medicine Economic News," reporters.

3M security system to sterilization, hospital hand washing and respiratory protection system solutions, and other medical products knew to outside world, in fact, it is in the drug delivery systems, dental and orthodontic fields are also full of strength.

According to the 3M2010 Annual Report, its revenue $ 26.7 billion, an increase of 22.6%, sales of medical products division $ 4.5 billion, up 5.2%, is the second most profitable business unit and division.

Wu Liang said, in China, Medical Products Division hopes to achieve two to three times the growth rate of GDP, to achieve this objective, multi-pronged approach, including mergers and acquisitions, R & D localization and market expansion to the Midwest, etc..

Through mergers and acquisitions to enter new markets

3M's chairman and CEO George Buckley said during last year's visit to China, 3M will spend 1 billion to 15 billion per year on acquisitions, sales, this figure accounts for about 2% to 4%.

George Buckley said it’s a very important tool to enter a blank field of technology and the rapid increase capacity by merger, it can help achieve business expansion in the scale of magnitude, while you want quick access to a vast market like China, by means of acquisition of local brands to cut is a very natural way.

This tactic has been confirmed in China. According to Wu Liang, last year 3M used $ 13 million on acquisition of a domestic leading enterprises of orthodontic equipment- Medical Equipment Co., Ltd. Hangzhou Aojie ,and obtain the corresponding intellectual property rights in Hangzhou, and build the 3M-Unitek's Asia R & D Center. In addition to research for the Asian population of orthodontic products, but also  Aojie based on the company's production base to further expand the production scale. It is reported that the main provider of AOJ low-end products, which complement 3M, meanwhile 3M will make up the product line of China

Last year, 3M in the United States to provide patients with the acquisition of an insulation system of the enterprise. The patient is closely related to insulation and reduce nosocomial infections, Wu Liang said, these products are now submitted to the SFDA registration, if goes well this year will enter the Chinese market.

to 3M ,another very coveted market is inhalation drug delivery system. Currently, China's most metered-dose inhalers using CFCs as a propellant,China has promised to ban the use of freon  in a short time. Wu Liang said that the implementation of non-chlorofluorocarbon metered-dose inhalers is a priority currently.

"The introduction of new products and acquisitions will help to enhance the medical division of the new product vitality index," Wu Liang said the index is the product of research and development over the past five years, accounting for a percentage of total sales, 3M averaged 38% in China, medical career approval by the Ministry of factors currently registered below this figure, our goal is to reach 30% to 40% after 5 years.

Western temptations

With the new medical reform, this year, the state hospital as a primary investment focus, the central and western regions is a top priority. Under the policy guidance, the Midwest and the potential of primary market for many foreign companies have been found and taken substantive action.

3M is no exception. In the 7th Shanghai International Forum on Infection Control, 3M combined the Chinese Medical Association launched the "support the western sense of Hundred training control."

Wu Liang said some hospitals in the western study found that the Midwest does have quite a number of ideas and operations specifications, the hospital's practices have much room for improvement, for enterprises, will have great market space."Midwest is not currently a large volume of business, but grow very fast, we should track closely, identify and service the Midwest market."

Meanwhile, Wu Liang also said that according to some of China's operating habits, 3M will be localized R & D and production, "local production is more important that need to shorten that time to provide products, headquarters hoping to have the capacity on growth area. "(Author: Wei Yun)